Project Details
Description
The Human Antibody Therapeutics facility supports the development of therapeutic antibodies. We will assist by isolating human antibodies from in-house constructed phage libraries to targets as suggested by the partner PI. It will be of critical importance that the partner PI has a substantial know-how of the biological system/target molecule, either from a clinical or basic scientific aspect. The objective is to deliver a reasonable number of candidate clones for further in vivo characterization in collaboration with the partner PI.
| Status | Active |
|---|---|
| Effective start/end date | 2016/01/01 → … |
Collaborative partners
- Lund University
- Science for Life Laboratory (SciLifeLab) (lead)
UKÄ subject classification
- Immunology in the medical area